These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35456526)

  • 1. New Peptide Based Fluconazole Conjugates with Expanded Molecular Targets.
    Brankiewicz W; Okońska J; Serbakowska K; Lica J; Drab M; Ptaszyńska N; Łęgowska A; Rolka K; Szweda P
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity.
    Ptaszyńska N; Gucwa K; Olkiewicz K; Heldt M; Serocki M; Stupak A; Martynow D; Dębowski D; Gitlin-Domagalska A; Lica J; Łęgowska A; Milewski S; Rolka K
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-Based Conjugates Containing Antimicrobial HLopt2 Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities.
    Ptaszyńska N; Gucwa K; Olkiewicz K; Łȩgowska A; Okońska J; Ruczyński J; Gitlin-Domagalska A; Dȩbowski D; Milewski S; Rolka K
    ACS Chem Biol; 2019 Oct; 14(10):2233-2242. PubMed ID: 31513374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.
    Ng SMS; Yap JM; Lau QY; Ng FM; Ong EHQ; Barkham T; Teo JWP; Alfatah M; Kong KW; Hoon S; Arumugam P; Hill J; Brian Chia CS
    Eur J Med Chem; 2018 Apr; 150():479-490. PubMed ID: 29549835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
    Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
    Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide conjugates of lactoferricin analogues and antimicrobials-Design, chemical synthesis, and evaluation of antimicrobial activity and mammalian cytotoxicity.
    Ptaszyńska N; Olkiewicz K; Okońska J; Gucwa K; Łęgowska A; Gitlin-Domagalska A; Dębowski D; Lica J; Heldt M; Milewski S; Ng TB; Rolka K
    Peptides; 2019 Jul; 117():170079. PubMed ID: 30959143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole.
    Ahmad A; Khan A; Manzoor N
    Eur J Pharm Sci; 2013 Jan; 48(1-2):80-6. PubMed ID: 23111348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II: Antifungal Activity against Reference Strains and Clinical Isolates of
    Aguirre-Guataqui K; Márquez-Torres M; Pineda-Castañeda HM; Vargas-Casanova Y; Ceballos-Garzon A; Rivera-Monroy ZJ; García-Castañeda JE; Parra-Giraldo CM
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic
    Revie NM; Robbins N; Whitesell L; Frost JR; Appavoo SD; Yudin AK; Cowen LE
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.
    Liu S; Hou Y; Chen X; Gao Y; Li H; Sun S
    Int J Antimicrob Agents; 2014 May; 43(5):395-402. PubMed ID: 24503221
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition.
    Zhu B; Li Z; Yin H; Hu J; Xue Y; Zhang G; Zheng X; Chen W; Hu X
    Microbiol Spectr; 2022 Apr; 10(2):e0147821. PubMed ID: 35297651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans.
    Han B; Chen J; Yu YQ; Cao YB; Jiang YY
    Microbiol Immunol; 2016 Feb; 60(2):82-92. PubMed ID: 26891940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
    Zhang M; Yan H; Lu M; Wang D; Sun S
    Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
    Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
    J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans.
    Mora-Navarro C; Caraballo-León J; Torres-Lugo M; Ortiz-Bermúdez P
    J Pept Sci; 2015 Dec; 21(12):853-61. PubMed ID: 26470850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.